Douglas J. Manion

Companies

• Aclaris Therapeutics, Inc.Board member Feb 3, 2023 to Jan 3, 2024¹
• Aclaris Therapeutics, Inc.Chief executive officer Feb 3, 2023 to Jan 3, 2024¹
• Aclaris Therapeutics, Inc.Chief operating officer Aug 2, 2022 to Aug 2, 2022²
• Arena PharmaceuticalsEVP Research & Development Jul 29, 2021 to Mar 11, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAclaris Therapeutics, Inc. ACRS41,813 shares⁴$141.3K at $3.38Jan 1, 2024
• Arena Pharmaceuticals ARNA0 shares⁵Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 1, 2024Shares withheld for tax 9,125 shares at $1.05 of Aclaris Therapeutics, Inc.⁴
• Jan 1, 2024Exercised options 27,000 shares of Aclaris Therapeutics, Inc.⁴
• Aug 1, 2023Shares withheld for tax 4,437 shares at $9.81 of Aclaris Therapeutics, Inc.⁶
• Aug 1, 2023Exercised options 15,575 shares of Aclaris Therapeutics, Inc.⁶
• Mar 17, 2023Bought 6,300 shares at $7.86 of Aclaris Therapeutics, Inc.⁷
• Mar 9, 2023Bought 6,500 shares at $7.74 of Aclaris Therapeutics, Inc.⁸
• Mar 11, 2022Other 21,462 shares of Arena Pharmaceuticals⁵
• Mar 11, 2022Other 15,000 shares of Arena Pharmaceuticals⁵
• Jan 3, 2022Granted 21,462 shares of Arena Pharmaceuticals⁹